DoggyStat rapidly resolves non-infectious canine diarrhea

Related Posts

08Oct

Silo Pharma achieves milestone – Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology

Silo Pharma, Inc. a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their... read more
22Dec

Endocannabinoid Pathway Targeted Drug Demonstrates Proof-of-Concept Efficacy in a Cutaneous Lupus Erythematosus Mouse Model

Hoth has a partnership agreement with Zylö Therapeutics Inc., to co-develop a new topical treatment for patients with Cutaneous Lupus... read more
16Mar

Drink of the Week: Archer Roose Wines

In 2015, Marian Leitner-Waldman found herself pondering a familiar question during dinner: Should she open a whole bottle of wine... read more
09Jun

RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product

RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from... read more
10May

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents... read more
23Nov

Pitt researchers’ work on bone growth heads to space

What do a dentist, a super glue, and the International Space Station have in common? Not much normally, but starting... read more
15Dec

Astrocyte Pharmaceuticals Announces Appointment of Christine Gallagher to Board of Directors

Astrocyte Pharmaceuticals Inc., a drug discovery and development company developing novel cerebroprotective therapeutics for patients with brain injuries, announced today... read more
23Oct

ZetrOZ Receives Funding from the National Institute of Health to Find New Ways to Reduce Arthritic Pain for Over 60 Million Americans Using Non-Narcotic, Non-Surgical Technology

ZetrOZ Systems, developers of sustained acoustic medicine (SAM), an FDA-cleared home-use ultrasound device that helps reduce pain associated with tendon,... read more
30Jan

Regroup Mass Notification to Attend Global Conference on Health Information and Technology; HIMSS 2019

Regroup Mass Notification, the award-winning provider of mass communication solutions, announced that it will be attending The HIMSS Global Conference... read more
25Jun

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Akston Biosciences Corporation and Biolexis, a Strides Group Company, today announced results from a Phase II/III clinical trial in India... read more